Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the 3rd Global Awards for Advancing Chronic Pain Research (ADVANCE), an independently-reviewed, competitive grants program.
Our mission is to fund innovative, novel research proposals that seek to advance the understanding and management of chronic pain.
Proposals will be reviewed by an external multidisciplinary, Independent Review Committee comprising renowned, global experts in chronic pain. Proposals will be reviewed based on
area of interest, originality, scientific merit, and feasibility.
A total of US $1,000,000 will be available to fund approximately 5 individual research proposals of between US $50,000 and US $200,000.
Click on the tabs opposite for full details of the types and areas of eligible research, applicant eligibility criteria, deadlines, and how to apply.
The deadline for submission is September 15, 2020 (by 11:59 pm Eastern Daylight Time in the United States).
Please contact us to request further information on the program.